The Effect of Oxidant Hypochlorous Acid on Platelet Aggregation and Dityrosine Concentration in Chronic Heart Failure Patients and Healthy Controls

被引:8
作者
Mongirdiene, Ausra [1 ]
Laukaitiene, Jolanta [1 ,2 ]
Skipskis, Vilius [3 ]
Kasauskas, Arturas [1 ]
机构
[1] Lithuanian Univ Hlth Sci, Med Acad, Dept Biochem, LT-44307 Kaunas, Lithuania
[2] Hosp Lithuanian Univ Hlth Sci, Dept Cardiol, LT-44307 Kaunas, Lithuania
[3] Lithuanian Univ Hlth Sci, Inst Cardiol, Lab Mol Cardiol, LT-44307 Kaunas, Lithuania
来源
MEDICINA-LITHUANIA | 2019年 / 55卷 / 05期
关键词
platelet; heart failure; oxidant; dityrosine; hypochlorous acid; COAGULATION SYSTEM; BLOOD-PLATELETS; SINUS RHYTHM; OXIDIZED LDL; FIBRINOGEN; ACTIVATION; PLASMA; HDL; PEROXYNITRITE; LIPOPROTEINS;
D O I
10.3390/medicina55050198
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: One of the reasons for thrombosis in chronic heart failure (CHF) might be reactive forms of oxygen activating platelets. The aim of this study was to evaluate the effect of oxidant hypochlorous acid (HOCl) on platelet aggregation and dityrosine concentration in CHF patients and healthy controls. Materials and Methods: CHF patients (n = 67) and healthy (n = 31) were investigated. Heart echoscopy, 6-min walking test, complete blood count, platelet aggregation, and dityrosine concentration were performed. Platelet aggregation and dityrosine concentration were measured in plasma samples after incubation with different HOCl concentrations (0.15, 0.0778, and 0.0389 mmol/L). Results: Platelet aggregation without oxidant was lower (p = 0.049) in CHF patients than in controls. The spontaneous platelet aggregation with oxidant added was higher in CHF patients (p = 0.004). Dityrosine concentration was also higher (p = 0.032) in CHF patients. Platelet aggregation was the highest in samples with the highest oxidant concentration in both healthy controls (p = 0.0006) and in CHF patients (p = 0.036). Platelet aggregation was higher in NYHA III group in comparison to NYHA II group (p = 0.0014). Concentration of dityrosine was significantly higher in CHF samples (p = 0.032). The highest concentration of dityrosine was obtained in NYHA IV group samples (p < 0.05). Intensity of platelet aggregation, analyzed with ADP, was correlated with LV EF (r = 0.42, p = 0.007). Dityrosine concentration was correlated with NYHA functional class (r = 0.27, p < 0.05). Conclusions: The increase in platelet aggregation in CHF and healthy controls shows the oxidant effect on platelets. The increase in dityrosine concentration in higher NYHA functional classes shows a higher oxidative stress in patients with worse condition.
引用
收藏
页数:12
相关论文
共 30 条
  • [11] Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm -: Effects of angiotensin-converting enzyme inhibitor and β-blocker therapy
    Gibbs, CR
    Blann, AD
    Watson, RDS
    Lip, GYH
    [J]. CIRCULATION, 2001, 103 (13) : 1746 - 1751
  • [12] The Role of Platelets in Atherothrombosis
    Kaplan, Zane S.
    Jackson, Shaun P.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2011, : 51 - 61
  • [13] Haem-assisted dityrosine-cross-linking of fibrinogen under non-thermal plasma exposure: one important mechanism of facilitated blood coagulation
    Ke, Zhigang
    Huang, Qing
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [14] Acquired Disorders of Platelet Function
    Konkle, Barbara A.
    [J]. HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 391 - 396
  • [15] Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade
    Magwenzi, Simbarashe
    Woodward, Casey
    Wraith, Katie S.
    Aburima, Ahmed
    Raslan, Zaher
    Jones, Huw
    McNeil, Catriona
    Wheatcroft, Stephen
    Yuldasheva, Nadira
    Febbriao, Maria
    Kearney, Mark
    Naseem, Khalid M.
    [J]. BLOOD, 2015, 125 (17) : 2693 - 2703
  • [16] Elevated levels of 8-iso-prostaglandin F2α in pericardial fluid of patients with heart failure -: A potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure
    Mallat, Z
    Philip, I
    Lebret, M
    Chatel, D
    Maclouf, J
    Tedgui, A
    [J]. CIRCULATION, 1998, 97 (16) : 1536 - 1539
  • [17] Mironchuk N. N., 2013, MED SCI, V5, P333
  • [18] Changes in Parameters of Coagulation System After Treatment of Chronic Heart Failure with β-Adrenoblockers, Angiotensin-Converting Enzyme Inhibitors, Calcium Antagonists, Diuretics, Anticoagulants, Antiagregants, Cardiac Glycosides, and Physical Exercise
    Mongirdiene, Ausra
    [J]. MEDICINA-LITHUANIA, 2011, 47 (04): : 238 - 243
  • [19] The coagulation system changes in patients with chronic heart failure
    Mongirdiene, Ausra
    Kursvietiene, Lolita
    Kasauskas, Arturas
    [J]. MEDICINA-LITHUANIA, 2010, 46 (09): : 642 - 647
  • [20] The oxidative modification hypothesis of atherosclerosis: The comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma
    Nakajima, K
    Nakano, T
    Tanaka, A
    [J]. CLINICA CHIMICA ACTA, 2006, 367 (1-2) : 36 - 47